Lecturer in Pharmacological Sciences
BSc BSc(Hons) MRes PhD
|Contact Campus||Sandy Bay Campus|
|Telephone||+61 3 6226 1003|
|Fax||+61 3 6226 2870|
Dr Dietis teaches and coordinates Pharmacology in undergraduates (Bachelors of Pharmacy, Bachelors of Medical Research) and postgraduate cohorts (Masters of Pharmaceutical Sciences). He is the Coordinator of the program Introduction to Pharmacology of the Medicines Australia's Continuing Education Programs (CEP), actively involved in its development and online teaching.
Dr Dietis' teaching philosophy incorporates the development of two basic strategies: content delivery and student development. His content delivery strategy is based on the rationalization of pharmacological concepts and simplification of complicated pharmacological principles using explanatory audiovisual paradigms and application examples that deepen understanding, enhance learning and strengthen memory retention/consolidation. His student development strategy is based on the implementation of mentoring activities, discussion forums and scientific seminars that aim to enhance student motivation for continuing efficient self-directed learning and scientific critical thinking.
the Tasmanian Association of Pharmacy Students (TAPS)Dr Dietis has been awarded with the iQube Award by the University of Leicester for research excellence in his doctorate work. He also received the Bain Memorial Award and the Schachter Award by the British Pharmacological Society. In 2013 he received a Teaching Merit Certificate Award by the University of Tasmania for teaching excellence. He also received a student recognition award in 2013, as voted by the Tasmanian Association of Pharmacy Students (TAPS) for outstanding teaching contribution to the Division of Pharmacy.
Nikolas has graduated from the University of Portsmouth (UK) with a BSc in Pharmacology and later from Nottingham Trent University (UK) with a BScHons in Pharmacology & Neuroscience. After working for five years in the pharmaceutical industry sector, he graduated from the Nottingham Trent University with a Masters by Research in Applied Biosciences (Neuroscience), working on opioid receptor dimerization with Prof Mark Darlison at the Natural Sciences Research Centre (NSRC). He received a doctorate scholarship from the HOPE Foundation for Cancer Research and completed his PhD at the University of Leicester (UK), working with Prof Dave Lambert on the pharmacological characterization of bifunctional opioids as novel effective ligands for cancer pain.
Nikolas was involved in Secondary Education, teaching Biology and Chemistry A-levels in the UK for three years. He served as a member of the Young Pharmacologists Committee at the British Pharmacological Society and Chaired the East Midlands Universities Association Postgraduate Research Conference in 2010. He serves a Reviewer for the European Journal of Medicinal Chemistry and the Journal of Pharmacology and Experimental Therapeutics (JPET). He is also an Editorial Board Member of the UK Journal of Pharmaceutical and Biosciences (UKJPB). He has been an active member of various Pharmacological and Neuroscience Societies & Foundations (Brain Foundation, BPS, SfN, GPS, BNA, APS), as well as the International Society for the Study of Pain (IASP), contributing to a number of activities & projects since 2001.
In 2012 he joined the University of Tasmania as a Lecturer in Pharmacological Sciences at the Division of Pharmacy, School of Medicine.
Dr Dietis' interests span around the molecular neuropharmacology of G protein-coupled receptors in the CNS and the identification of novel neuropharmacological ligands in vitro and in vivo. His current work focuses on opioid receptor pharmacology and the role of the opioidergic system in the development of chronic pain conditions, mental disorders and neurodegenerative diseases.
Alignment with Research Themes of the Faculty of Health: Translational Neurosciences & Dementia, Prevention & Management of Chronic Disease
Listed below are examples of projects that Dr Dietis' team is currently involved in:
Authorised by the Associate Head, Pharmacy
4 February, 2015